Cash Equivalents - Erasca Inc (NASDAQ:ERAS) - Alpha Spread

Erasca Inc
NASDAQ:ERAS

Watchlist Manager
Erasca Inc Logo
Erasca Inc
NASDAQ:ERAS
Watchlist
Price: 2.97 USD 2.77% Market Closed
Market Cap: 810.3m USD
Have any thoughts about
Erasca Inc?
Write Note

Erasca Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Erasca Inc
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Erasca Inc
NASDAQ:ERAS
Cash Equivalents
$93.1m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$13.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$2.8B
CAGR 3-Years
-17%
CAGR 5-Years
-24%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9.3B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
8%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$4.6B
CAGR 3-Years
-9%
CAGR 5-Years
7%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$1.9B
CAGR 3-Years
-2%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is Erasca Inc's Cash Equivalents?
Cash Equivalents
93.1m USD

Based on the financial report for Dec 31, 2023, Erasca Inc's Cash Equivalents amounts to 93.1m USD.

What is Erasca Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
12%

Over the last year, the Cash Equivalents growth was -67%. The average annual Cash Equivalents growth rates for Erasca Inc have been 12% over the past three years .

Back to Top